 |
(1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate- |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| USA Market Approval | USA |
| USA Designation Date | 2009-02-17 00:00:00 |
| Sponsor | Pfizer, Inc.;500 Arcola Road;Collegeville, Pennsylvania, 19426 |
Related Access Program